Amal Therapeutics competitorsClear all

Amal Therapeutics's top competitors include Neovii, Eutilex, Foghorn Therapeutics and Reflexion Medical.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Amal Therapeutics
Amal Therapeutics
Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology.
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Reflexion Medical
Reflexion Medical
RefleXion Medical is developing the biology-guided radiotherapy system for cancer treatment.
Founding Date
Founding Date
N/A
Founding Date
2003
Founding Date
2015
Founding Date
2016
Founding Date
2009
Type
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Genève, CH HQ
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Locations
KR HQ
Locations
Cambridge, US HQ
Cambridge, US
Locations
Hayward, US HQ
Employees
Employees
21
Employees
86
Employees
108
Employees
85
Employees
2461% decrease
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
763
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
4.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
91.67%
Alexa Website Rank
Alexa Website Rank
349686
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
340238
Alexa Website Rank
322400
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2.9
Employee Rating
4.3

Funding

Total funding raised
Total funding raised
$ 45.5m
Total funding raised
N/A
Total funding raised
$ 18.9m
Total funding raised
$ 50m
Total funding raised
$ 263.6m
For sources of this data, please see the company profile

View company profiles

Neovii
HQ
Rapperswil-Jona, CH
Employees
86

Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.

View company
Eutilex
HQ
KR
Employees
108

Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.

View company
Foghorn Therapeutics
HQ
Cambridge, US
Employees
85

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company
Reflexion Medical
HQ
Hayward, US
Employees
246↓ 1% decrease

RefleXion Medical is developing the biology-guided radiotherapy system for cancer treatment.

View company